Dalmevin 50 mg tablete

Name	Dalmevin 50 mg tablete
Marketing Authorisation Number	HR-H-215024398
Active Substance	vildagliptin
Composition	svaka tableta sadrži 50 mg vildagliptina
Pharmaceutical Form	tableta
Manufacturer	Medochemie Ltd., Limassol, Cipar
Marketing Authorisation Holder	Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar
Marketing Authorisation Date	07.01.2022
MA Period of Validity	unlimited
Classification Number	UP/I-530-09/21-02/140
Registration Number	381-12-01/38-22-04
Prescription	na recept
Type of prescription	ponovljivi recept
Distribution	u ljekarni
Advertising to general public	zabranjeno
ATC Code	A10BH02
Medicinal product marketed in the Croatia	Da
SmPC	download
PL	download
Public Assessment Report	download

Packaging description	MA Number for Packaging	Marketing status	Shortage status
7 tableta u blisteru, u kutiji	HR-H-215024398-01	-	-
14 tableta u blisteru, u kutiji	HR-H-215024398-02	-	-
28 tableta u blisteru, u kutiji	HR-H-215024398-03	-	-
30 tableta u blisteru, u kutiji	HR-H-215024398-04	-	-
56 tableta u blisteru, u kutiji	HR-H-215024398-05	-	-
60 tableta u blisteru, u kutiji	HR-H-215024398-06	-	-
90 tableta u blisteru, u kutiji	HR-H-215024398-07	-	-
112 tableta u blisteru, u kutiji	HR-H-215024398-08	-	-
180 tableta u blisteru, u kutiji	HR-H-215024398-09	-	-
336 tableta u blisteru, u kutiji	HR-H-215024398-10	-	-

Medicinal Products